Tendencias21

Study drug is first to help patients with recurrent low-grade ovarian cancer

Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.

Fuente : http://www.eurekalert.org/pub_releases/2013-02/uot…

RedacciónT21

RedacciónT21

Hacer un comentario